ArticleCancers2022
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer.
Davide Saronni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleCancers2022
Davide Saronni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.